Wakefield Asset Management Lllp Lantheus Holdings, Inc. Transaction History

Wakefield Asset Management Lllp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$82.41 - $99.65 $215,337 - $260,385	-2,613 Reduced 24.43%	8,082 $678,000
Q1 2023 May 02, 2023	BUY	$47.76 - $82.86 $907 - $1,574	19 Added 0.18%	10,695 $882,000
Q4 2022 Jan 30, 2023	SELL	$48.76 - $77.67 $22,429 - $35,728	-460 Reduced 4.13%	10,676 $544,000
Q3 2022 Nov 07, 2022	SELL	$61.42 - $86.29 $3,439 - $4,832	-56 Reduced 0.5%	11,136 $783,000
Q2 2022 Aug 09, 2022	BUY	$55.54 - $72.65 $621,603 - $813,098	11,192 New	11,192 $739,000

539

69.9M

651K

459K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $5.63B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Wakefield Asset Management Lllp, based on Form 13F filings with the SEC.

Stay updated on Wakefield Asset Management Lllp with notifications on news.